CKMT2 Gene - Mitochondrial Creatine Kinase 2

Key enzyme in cellular energy homeostasis, predominantly expressed in cardiac and skeletal muscle.

Gene Information Card

Symbol CKMT2
Full Name Creatine kinase, mitochondrial 2 (sarcomeric)
Gene Type Protein coding
Chromosomal Location 5q14.1
NCBI Gene ID 1160 ncbi.nlm.nih.gov/gene/1160
Ensembl ID ENSG00000113520
UniProt ID P17540
OMIM ID 602375
HGNC ID 1997
Aliases CKMT2, SMTCK, MTCK, MtCK, sarcomeric mitochondrial creatine kinase

Description

CKMT2 encodes the sarcomeric isoform of mitochondrial creatine kinase, a key enzyme in the creatine/phosphocreatine energy shuttle. It is primarily expressed in cardiac and skeletal muscle, where it catalyzes the reversible transfer of a phosphate group from ATP to creatine, generating phosphocreatine. This high-energy phosphate reservoir is crucial for maintaining cellular ATP levels during periods of high energy demand. Mutations in CKMT2 have been associated with mitochondrial myopathy and cardiomyopathy.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cardiomyopathy, dilated, 1BB (CMD1BB) Impaired energy buffering due to reduced phosphocreatine synthesis in cardiac muscle OMIM #615235; ClinVar
Mitochondrial myopathy Defective mitochondrial creatine kinase activity leads to energy deficiency in skeletal muscle OMIM; PubMed studies
Creatine deficiency syndromes (secondary) Altered CKMT2 expression may contribute to systemic creatine metabolism disorders NCBI Gene; literature review

Expression Profile

Tissue Expression
Tissue nTPM level
Heart 78.2 High
Skeletal muscle 65.4 High
Brain 1.3 Low
Liver 0.2 Not detected
Kidney 0.5 Not detected
Cell Line Expression
Cell Line nTPM Notes
Cardiomyocytes (AC16) 82.1 High expression; consistent with cardiac origin
Skeletal muscle myoblasts (LHCN-M2) 70.5 High expression; differentiation-dependent
HEK293 0.8 Very low; non-muscle cell line
HeLa 0.3 Not detected
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.122G>A (p.Arg41Gln) Missense <0.01% Reduced enzyme activity; associated with dilated cardiomyopathy
c.563C>T (p.Thr188Met) Missense <0.01% Impaired substrate binding; reported in mitochondrial myopathy
c.784delC (p.Leu262Trpfs*12) Frameshift <0.001% Loss of function; truncation of C-terminal domain
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense mutations (e.g., c.784delC) lead to truncated, non-functional protein, reducing phosphocreatine production.

Gain of Function (GOF)

No gain-of-function mutations reported for CKMT2.

Dominant Negative (DN)

Missense mutations (e.g., p.Arg41Gln) may exert dominant-negative effects by interfering with dimerization or substrate binding.

Pathways

Creatine metabolism (Reactome: R-HSA-71291)
Muscle contraction (Reactome: R-HSA-397014)
Energy metabolism (KEGG: hsa04932)

Protein Summary

CKMT2 is a 417-amino acid protein (UniProt P17540) localized to the mitochondrial intermembrane space. It forms homodimers or heterodimers with CKMT1A/B. The protein contains a mitochondrial transit peptide (residues 1-39) and a creatine kinase domain (residues 40-417). It is essential for the rapid regeneration of ATP in muscle tissues. Structural studies show a conserved active site with Arg41 and Thr188 critical for catalysis.

Related Products

Product name Cat.No. Species Gene ID
CKMT2 Knockout HEK293 Cell Line EDJ-KQ4281 Human 1160 Details Get a Quote
CKMT2 Knockout HeLa Cell Line EDJ-KQ52916 Human 1160 Details Get a Quote
CKMT2 Knockout A-549 Cell Line EDJ-KQ61383 Human 1160 Details Get a Quote
CKMT2 Knockout HCT 116 Cell Line EDJ-KQ69878 Human 1160 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: